← FDA Drug Approvals (Drugs@FDA)

BEXAROTENE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASCENT PHARMS INC · Approved 2024-09-06

Drug application

FDA Application #

ANDA208628

Application type

Abbreviated New Drug Application (Generic)

Brand name

BEXAROTENE

Generic name

BEXAROTENE

Active ingredients

BEXAROTENE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

ASCENT PHARMS INC

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2024-09-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown